About us

Budapest-based Euroventures is one of the longest-established and leading independent private equity and venture capital firms in Central Europe, with a proven ability to achieve international exits over two decades in a fast-changing environment.

It has advised or is advising five investment programmes totalling over €180m since 1989, with a focus on funding INNOVATION and GROWTH in Hungary and Central Europe.

The investors in Euroventures funds have mainly been international institutional Investors, and in the case of Euroventures IV included EU, Hungarian and Swiss government SME programmes.  

Euroventures' nearly 50 current and former portfolio companies illustrate the commitment to provide steady support through the cycles of the regional and global economy.

Its professional team members have many decades of private equity / venture capital experience between them. Investments have ranged from the milk industry and wine production to leading edge technologies in the fields of medtech, big data, security, and IoT among others.

Euroventures is a founding member of the Hungarian Venture Capital Association and complies with the conduct, governing principles and valuation/reporting guidelines of Invest Europe.

Investment funds


Euroventures supports its partners' growth with funding, advice and contacts, and has participated, with management and co-owners, in some highly successful exits, including IPOs (Vienna, NASDAQ, NYSE), trade sales to international corporations and sales to management.

As well as making money for investors in its funds, Euroventures' track record over 25 years has delivered excellent returns to founders, management teams and co-investors.


Investment policy

Currently Euroventures targets innovative, growing companies seeking €1-5 million to fund technical development, investment and expansion.

Past investments 

Euroventures has invested in around 50 businesses, many of which have been successfully exited.  Here are some recent examples:

A Node.js consultant and developer with increasing expertise in Kubernetes and Microservices. Status: Current portfolio

Parcel delivery price comparison and transactional websites. Status: Current portfolio

Advanced software tools for automatic provisioning of Hadoop clusters. Status: Strategic sale to Hortonworks

Professional chemical service provider to support pharmaceutical development with pilot scale manufacturing facilities. Status: Strategic sale

Leading global software development outsourcing. Status: IPO on NYSE

Leading security technology for end-to-end file sharing and sychronisation. Status: Secondary sale

Credit and banking information and price comparison website. Status: Current portfolio

Embedded Video Analytics in Berkeley and Budapest. Status: Strategic sale to Sensity and Verizon

Leading front-end banking technology and implementation. Status: Trade sale to Misys

HLA type next generation sequencing. Status: Current portfolio

Medimass invented an intelligent surgical laser connected to mass spectrometer. Status: Strategic sale to Waters Corp.


Tánczos Péter
Tánczos Péter


Thomas Howells
Thomas Howells


Zoltán Tóth
Zoltán Tóth


Norbert Bial
Norbert Bial

Investment Manager

Mariann Ivanics
Mariann Ivanics

Compliance Manager

Dóra Szokolovszky
Dóra Szokolovszky

Investment Analyst

Contact us

H-1124 Budapest, Mártonhegyi út 61/A

+36 1 309 7900